Published in J Surg Res on December 01, 1988
Oncolytic viruses. Invest New Drugs (1999) 0.81
The role of cholecystectomy in acquired immunodeficiency syndrome. J Am Coll Surg (1997) 2.57
A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. Cancer Res (2000) 1.86
Loss of heterozygosity at D14S62 and metastatic potential of breast cancer. J Natl Cancer Inst (1999) 1.75
The suppressive effect of immunization on the proliferative responses of rat T cells in vitro. J Immunol (1975) 1.57
Massive localized lymphedema of the thigh in a morbidly obese patient. Eur J Surg Oncol (2009) 1.41
Adjuvant immunotherapy for patients with melanoma: are patients with melanoma of the head and neck candidates for this therapy? Head Neck (1997) 1.38
Tibiofemoral movement 2: the loaded and unloaded living knee studied by MRI. J Bone Joint Surg Br (2000) 1.35
Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas. J Natl Cancer Inst (1992) 1.33
Postoperative complications after thoracic and major abdominal surgery in patients with and without obstructive lung disease. Chest (1993) 1.25
Recurrent malignant chondroid syringoma of the foot: a case report and review of the literature. Am J Clin Oncol (2000) 1.21
Results of gal-knockout porcine thymokidney xenografts. Am J Transplant (2009) 1.19
Ectopic supernumerary kidney, a cause of para-aortic mass: case report and review. Am Surg (2001) 1.19
Comparative bone growth behavior in granules of bioceramic materials of various sizes. J Biomed Mater Res (1999) 1.17
Gestational carcinoma of the female breast. Curr Probl Cancer (1983) 1.17
Mucin-producing carcinoma of the prostate: review of 88 cases. Urology (1999) 1.15
Cholecystectomy in the elderly. Am J Surg (1988) 1.13
Oral malignant melanoma in Japan. Oral Surg Oral Med Oral Pathol (1994) 1.12
Two closely related antigens expressed on granulocytes, macrophages and some reticular elements in rat lymphoid tissues: characterization by monoclonal antibodies. Immunology (1984) 1.10
Particulate bioglass compared with hydroxyapatite as a bone graft substitute. Clin Orthop Relat Res (1997) 1.09
Pyogenic liver abscess secondary to asymptomatic sigmoid diverticulitis. Ann Surg (1976) 1.08
Separation of T cell subpopulations capable of DNA synthesis, lymphotoxin release, and regulation of antigen and phytohemagglutinin responses on the basis of density and adherence properties. Proc Natl Acad Sci U S A (1975) 1.07
Survival after first recurrence of breast cancer. The Miami experience. Cancer (1992) 1.05
Investigation of taxol as a potential radiation sensitizer. Cancer (1993) 1.05
A novel degradative pathway of 2-nitrobenzoate via 3-hydroxyanthranilate in Pseudomonas fluorescens strain KU-7. FEMS Microbiol Lett (2000) 1.04
Inflammatory oncotaxis after testing the skin of the cancer patient. Cancer (1981) 1.00
The incidence of the patellar clunk syndrome in a recently designed mobile-bearing posteriorly stabilised total knee replacement. J Bone Joint Surg Br (2009) 0.99
The suppressive effect of immunization on the proliferative responses of rat T cells in vitro. II. Abrogation of antigen-induced suppression by selective cytotoxic agents. J Immunol (1976) 0.96
Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer (1995) 0.95
Long-term survival after locally aggressive anorectal melanoma. Am Surg (1998) 0.95
Total hip arthroplasty with a modified cementing technique using hydroxyapatite granules. J Arthroplasty (2001) 0.94
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up. Breast Cancer Res Treat (2012) 0.94
Mycosis fungoides bullosa. Am J Dermatopathol (1990) 0.94
Appendicitis in patients with acquired immunodeficiency syndrome. J Am Coll Surg (1997) 0.93
Reduction in recalcitrant pulmonary hypertension after operation for atrial septal defect. Ann Thorac Surg (2001) 0.93
Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation. J Clin Invest (1995) 0.93
The shapes and relative movements of the femur and tibia at the knee. Orthopade (2000) 0.93
Lung carcinoma in 1,336 patients. Am J Clin Oncol (1991) 0.91
Murine lymphocyte comitogenesis by phorbol esters, and its inhibition by retinoic acid and inhibitors of polyamine biosynthesis. Toxicol Appl Pharmacol (1981) 0.91
Sarcomatoid transitional cell carcinoma originating from a duplicated renal pelvis. Int J Urol (2001) 0.91
Negative appendicectomy rate as a quality metric in the management of appendicitis: impact of computed tomography, Alvarado score and the definition of negative appendicectomy. Ann R Coll Surg Engl (2012) 0.91
Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers. Breast Cancer Res Treat (2011) 0.90
Tacrolimus clearance is age-dependent within the pediatric population. Bone Marrow Transplant (2000) 0.89
Anteroposterior and rotational movement of femur during knee flexion. Clin Orthop Relat Res (1999) 0.89
[Seminal vesicle cyst with ipsilateral renal agenesis: a case report]. Hinyokika Kiyo (2001) 0.89
Reactive histiocytic hyperplasia with hemophagocytosis in hematopoietic organs: a reevaluation of the benign hemophagocytic proliferations. Hum Pathol (1988) 0.89
Characterization of tumorigenicity, mortality, metastasis, and splenomegaly of two cultured murine colon lines. Cancer Res (1981) 0.88
In vitro responses of rat lymphocytes following adult thymectomy. III. Prevention by thymic factor of increased suppressor activity in the spleen. Cell Immunol (1976) 0.88
Hydroxyapatite granules interposed at bone-cement interface in total hip replacements: histological study of retrieved specimens. J Biomed Mater Res (2000) 0.87
A new approach in specific, active immunotherapy. Cancer (1977) 0.86
Pigmented villonodular synovitis of the temporomandibular joint: differential diagnosis and case report. Br J Oral Maxillofac Surg (2004) 0.85
Colon cancer cell vaccine prepared with replication-deficient vaccinia viruses encoding B7.1 and interleukin-2 induce antitumor response in syngeneic mice. Cancer Immunol Immunother (1998) 0.85
Carcinoma of the breast during pregnancy: a review and update on treatment options. Surg Oncol (1999) 0.85
A Southeastern Cancer Study Group phase I/II trial with vaccinia melanoma oncolysates. Cancer (1986) 0.85
Carcinoma after enucleation of a calcifying odontogenic cyst: a case report. J Oral Maxillofac Surg (1993) 0.85
A phase I/II SECSG (Southeastern Cancer Study Group) pilot study of surgical adjuvant immunotherapy with vaccinia melanoma oncolysates (VMO). Am Surg (1986) 0.84
Positive relationship of clinical and serologic responses to vaccinia melanoma oncolysate. Arch Surg (1987) 0.84
Predominant expression of the src homology 2-containing tyrosine phosphatase protein SHP2 in vascular smooth muscle cells. Virchows Arch (1997) 0.83
Naturally occurring 5-lipoxygenase inhibitor. II. Structures and syntheses of ardisianones A and B, and maesanin, alkenyl-1,4-benzoquinones from the rhizome of Ardisia japonica. Chem Pharm Bull (Tokyo) (1993) 0.83
Carrageenan-induced suppression of T lymphocyte proliferation in the rat: in vitro production of a suppressor factor by peritoneal macrophages. J Reticuloendothel Soc (1980) 0.83
Immunoregulation of Heymann's nephritis. I. Induction of suppressor cells. J Immunol (1979) 0.83
Coronary artery bypass grafting in patients with human immunodeficiency virus. J Card Surg (1997) 0.83
The effects of polyethylene cup thickness on wear of total hip prostheses. J Mater Sci Mater Med (1998) 0.82
Optimal mastectomy timing. J Natl Cancer Inst (1992) 0.82
Active specific immunotherapy with vaccinia colon oncolysate enhances the immunomodulatory and antitumor effects of interleukin-2 and interferon alpha in a murine hepatic metastasis model. Cancer Immunol Immunother (1990) 0.82
Cholecystectomy in the elderly. Am Surg (1988) 0.82
Kinetic study of T lymphocytes after sensitization against soluble antigen. III. Potentiation and suppression of the PHA response by antigen-activated lymphocytes of low density. J Exp Med (1975) 0.82
Direct activation of mast cells by prosthetic biomaterial particles. J Mater Sci Mater Med (1998) 0.81
Collagen VI deficiency in Ullrich's disease. Ann Neurol (2001) 0.81
Cellular immunosenescence in F344 rats: decreased natural killer (NK) cell activity involves changes in regulatory interactions between NK cells, interferon, prostaglandin and macrophages. Mech Ageing Dev (1984) 0.81
Impairment of recognition memory and hippocampal long-term potentiation after acute exposure to clioquinol. Neuroscience (2010) 0.81
Comparison of three tumor markers--CA-125, lipid-associated sialic acid (LSA), and NB/70K--in monitoring ovarian cancer. Gynecol Oncol (1990) 0.81
Crohn's disease of the appendix. Surgery (1990) 0.81
A preliminary trial of vaccinia oncolysates in the treatment of recurrent melanoma with serologic responses to the treatment. J Biol Response Mod (1983) 0.81
A cemented mobile-bearing total knee replacement prevents periprosthetic loss of bone mineral density around the femoral component: a matched cohort study. J Bone Joint Surg Br (2010) 0.81
Gastric cancer in the elderly. Am Surg (1987) 0.81
Suppression of rat T cell proliferation by Corynebacterium parvum: T cell requirement for induction. J Reticuloendothel Soc (1978) 0.80
Microinvasive carcinoma of the cervix. Cancer (1992) 0.80
Zonisamide up-regulated the mRNAs encoding astrocytic anti-oxidative and neurotrophic factors. Eur J Pharmacol (2012) 0.80
Abnormal expression of laminin suggests disturbance of sarcolemma-extracellular matrix interaction in Japanese patients with autosomal recessive muscular dystrophy deficient in adhalin. J Clin Invest (1994) 0.80
Effect of splenectomy on the growth of murine colon tumors. J Surg Oncol (1983) 0.80
Composite islet-kidneys from single baboon donors cure diabetes across fully allogenic barriers. Am J Transplant (2011) 0.80
Effect of particles and interface conditions on fibrous tissue interposition between bone and implant. A particle challenge model in rabbit. J Mater Sci Mater Med (2000) 0.79
Intracolonic use of vancomycin for treatment of clostridium difficile colitis in a patient with a diverted colon: report of a case. Dis Colon Rectum (2001) 0.79
Effects of tumor-promoting agents on cells of the murine immune system: inhibition of antibody synthesis and of macrophage-mediated tumor cell cytotoxicity. Carcinog Compr Surv (1982) 0.79
Immunotherapy of a vaccinia colon oncolysate prepared with interleukin-2 gene-encoded vaccinia virus and interferon-alpha increases the survival of mice bearing syngeneic colon adenocarcinoma. J Immunother Emphasis Tumor Immunol (1994) 0.79
Segmental mastectomy without radiotherapy for T1 and small T2 breast carcinomas. Arch Surg (1990) 0.79
A novel cell-surface antigen expressed on most leukocytes and a minor cortisone-resistant population of thymocytes in rats: characterization by monoclonal antibodies. Microbiol Immunol (1985) 0.79
[A case of mediastinal non seminomatous germ cell tumor successfully treated with chemotherapy and curative surgery]. Kyobu Geka (2000) 0.79
3-deazaadenosine, a transmethylase inhibitor, suppresses the effect of lipopolysaccharide on release of prostacyclin and thromboxane. J Pharm Pharmacol (1981) 0.79
Overview analysis of adjuvant therapies for melanoma--a special reference to results from vaccinia melanoma oncolysate adjuvant therapy trials. Surg Oncol (2001) 0.79
Bilateral adrenalectomy in treatment of disseminated breast cancer. Am J Surg (1976) 0.78
Serial change in the atrial transport function after the radial incision approach. Ann Thorac Surg (2001) 0.78
Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model. Cancer Immunol Immunother (1994) 0.78
Total synthesis of ardisiaquinone A, a potent 5-lipoxygenase inhibitor, isolated from Ardisia sieboldii, and degree of 5-lipoxygenase inhibitory activity of its derivatives. Chem Pharm Bull (Tokyo) (1994) 0.78
Purification and characterization of cyclohexanone 1,2-monooxygenase from Exophiala jeanselmei strain KUFI-6N. Biosci Biotechnol Biochem (2000) 0.78
MGI 114: augmentation of antitumor activity when combined with topotecan. J Pediatr Hematol Oncol (2000) 0.77
Evidence of enhanced in vivo activity using tirapazamine with paclitaxel and paraplatin regimens against the MV-522 human lung cancer xenograft. Cancer Chemother Pharmacol (1999) 0.77